GENE ONLINE|News &
Opinion
Blog

Sanofi
Trials & Approvals Sanofi
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
Asia-Pacific Sanofi
Sanofi Licenses ABL Bio’s Bispecific Antibody for Parkinson’s Disease
2022-01-13
M&A SanofiBispecific AntibodyT-cell Activation
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
Licensing mRNA Technology
Sanofi Bets on Baidu’s Algorithm to Develop mRNA-Based Therapeutics
2021-11-23
Trials & Approvals Dupixent
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
COVID-19 mRNA Vaccine
Sanofi Abandons mRNA-Based COVID-19 Vaccine Plan but Indian Biotechs March On
2021-09-28
COVID-19 IL-6
WHO Recommends the Use of Sanofi’s and Roche’s Rheumatoid Arthritis Drugs to Cut COVID-19 Deaths
2021-07-12
Trials & Approvals Kidney Disease
Venglustat’s Phase 2/3 Trial Failure Pushes Sanofi to Drop Kidney Disease Program
2021-06-02
COVID-19 Vaccine
Sanofi, GSK Report Positive Trial Data for COVID-19 Vaccine
2021-05-18
M&A CAR T-cell Therapy
Sanofi to Go After mRNA Based Cancer Treatments, Acquires Cambridge Startup for $470 Million
2021-04-12
R&D AAV
Sanofi Joins Hands with German Biotech to Develop Improved AAV Capsids for Gene Therapies
2021-02-28
Trials & Approvals PD-1 Inhibitor
Libtayo’s Second Approval in One Month Sets Up Lung Cancer Duel with Merck’s Keytruda
2021-02-24
Trials & Approvals PD-1 Inhibitor
FDA Okay of Regeneron’s PD-1 Inhibitor Marks Entry of First Immunotherapy for Advanced Basal Cell Carcinoma
2021-02-12
M&A Immuno-oncology
Sanofi Looks to Bolster Immunology Pipeline By Acquiring Kymab for $1.5 Billion
2021-01-13
COVID-19 Vaccine
Sanofi/GSK Vaccine Delayed Due to Poor Immunogenicity in Older Adults
2020-12-15
1 2 3 4
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top